Pay in 4 interest-free payments of $5.79 Learn more
Ships within 48 hours · Estimated delivery Oct 19 - Oct 24
300 PI3K exerts effects through the Akt/PKB and protein kinase C cascades, 300 with Akt activation inhibiting GSK3 via mTOR and downstream elements, promoting glycogen synthesis
special focus on central nervous system imaging
White Papers / Tech Papers Tackling Poor Bioavailability with Early Formulation Strategies De-risking oral clinical development with UpperSolv Released By Upperton High failure rates in clinical trials, estimated at up to 90%, remain a major hurdle in drug development, with poor ADME (Absorption, Distribution, Metabolism, and Excretion) properties being one of the leading causes of late-stage attrition
der Pol YV , Yilma B, Morris VK, Chao C, Harris M, Guinney J, Kopetz S
